Trials / Recruiting
RecruitingNCT06915246
A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma
A Randomized Phase 2 Study of Carmustine Formulated With and Without Ethanol as Part of BEAM Chemotherapy Conditioning for Subjects With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation (AHCT)
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 49 (estimated)
- Sponsor
- VIVUS LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A phase 2 multicenter study of VI-0609 vs BiCNU in the BEAM high-intensity conditioning regimen for AHCT in subjects with lymphomas.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VI-0609 | Carmustine with Propylene Glycol |
| DRUG | BiCNU | Carmustine with Ethanol |
Timeline
- Start date
- 2025-03-12
- Primary completion
- 2027-03-31
- Completion
- 2027-04-30
- First posted
- 2025-04-08
- Last updated
- 2026-03-27
Locations
4 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06915246. Inclusion in this directory is not an endorsement.